Studies of Cognitive Change in Patients With Schizophrenia Following Novel Antipsychotic Treatment

Clozapine for the Treatment-Resistant Schizophrenic

1988 • 4,030 citations

What are the functional consequences of neurocognitive deficits in schizophrenia?

1996 • 3,505 citations

Wisconsin Card Sorting Test Manual – Revised and Expanded

1981 • 2,973 citations

Neurocognitive Deficits and Functional Outcome in Schizophrenia: Are We Measuring the "Right Stuff"?

2000 • 2,955 citations

Relation of sample size to the stability of component patterns.

1988 • 2,496 citations

Wisconsin Card Sorting Test manual

1993 • 1,489 citations

Positron Emission Tomographic Analysis of Central D1 and D2 Dopamine Receptor Occupancy in Patients Treated With Classical Neuroleptics and Clozapine

1992 • 1,420 citations

Risperidone in the treatment of schizophrenia

1994 • 1,205 citations

The Effects of Clozapine, Risperidone, and Olanzapine on Cognitive Function in Schizophrenia

1999 • 1,012 citations

Olanzapine versus Placebo and Haloperidol

1996 • 788 citations

The Effects of Atypical Antipsychotic Drugs on Neurocognitive Impairment in Schizophrenia: A Review and Meta-analysis

1999 • 698 citations

A Comparison of Clozapine and Haloperidol in Hospitalized Patients with Refractory Schizophrenia

1997 • 512 citations

Effects of Limiting Medicaid Drug-Reimbursement Benefits on the Use of Psychotropic Agents and Acute Mental Health Services by Patients with Schizophrenia

1994 • 487 citations

Neuropsychological Change in Early Phase Schizophrenia During 12 Months of Treatment With Olanzapine, Risperidone, or Haloperidol

2000 • 478 citations

Does risperidone improve verbal working memory in treatment-resistant schizophrenia?

1997 • 406 citations

Improvement in cognitive functions and psychiatric symptoms in treatment-refractory schizophrenic patients receiving clozapine

1993 • 403 citations

Neuropsychological Deficits in Schizophrenics

1994 • 387 citations

Clinical effects of clozapine in chronic schizophrenia: response to treatment and predictors of outcome

1994 • 380 citations

Effects of Six Months of Clozapine Treatment on the Quality of Life of Chronic Schizophrenic Patients

1990 • 351 citations

Symptoms, Cognitive Functioning, and Adaptive Skills in Geriatric Patients With Lifelong Schizophrenia: A Comparison Across Treatment Sites

1998 • 341 citations

Relation to sample size to the stability of component patterns.

1988 • 315 citations

Severity of symptoms in chronically institutionalized geriatric schizophrenic patients

1995 • 307 citations

The Effect of Clozapine on Cognition and Psychiatric Symptoms in Patients with Schizophrenia

1993 • 296 citations

The comparative efficacy and long-term effect of clozapine treatment on neuropsychological test performance

1994 • 283 citations

Cognitive functioning and positive and negative symptoms in schizophrenia

1991 • 277 citations

Cost effectiveness of clozapine in neuroleptic-resistant schizophrenia

1993 • 211 citations

Effects of clozapine on cognitive function in schizophrenia.

1994 • 200 citations

Neuroleptic drug-induced extrapyramidal syndromes and tardive dyskinesia

1991 • 193 citations

A Controlled Dose Comparison of Haloperidol in Newly Admitted Schizophrenic Patients

1990 • 187 citations

Sample size calculations in studies of test accuracy

1998 • 175 citations

Cognitive dysfunction in schizophrenia: comparison of treatment with atypical antipsychotic agents and conventional neuroleptic drugs

1996 • 172 citations

Clozapine's effectiveness for patients in state hospitals: results from a randomized trial.

1996 • 171 citations

The Effects of Clozapine on Symptom Reduction, Neurocognitive Function, and Clinical Management in Treatment-Refractory State Hospital Schizophrenic Inpatients

1996 • 135 citations

Extrapyramidal Symptoms in Patients Treated With Risperidone

1997 • 129 citations

Effects of Risperidone in Tardive Dyskinesia: An Analysis of the Canadian Multicenter Risperidone Study*

1995 • 127 citations

Risperidone, negative symptoms and cognitive deficit in schizophrenia: an open study

1997 • 122 citations

Improvement of Cognitive Function in Schizophrenic Patients Receiving Clozapine or Zotepine: Results from a Double-Blind Study

1997 • 108 citations

Risperidone versus haloperidol for perception of emotion in treatment-resistant schizophrenia: preliminary findings

1998 • 106 citations

Relationships between changes in symptom ratings, neuropsychological test performance and quality of life in schizophrenic patients treated with clozapine

1997 • 104 citations

Efficacy and safety of risperidone in the long-term treatment of patients with schizophrenia

1995 • 104 citations

Clozapine Treatment of Outpatients With Schizophrenia: Outcome and Long-Term Response Patterns

2000 • 103 citations

Economic and Health State Utility Determinations for Schizophrenic Patients Treated With Risperidone or Haloperidol

1997 • 100 citations

Risperidone versus Haloperidol on Secondary Memory: Can Newer Medications Aid Learning?

1999 • 95 citations

Clinical and Neurocognitive Effects of Clozapine and Risperidone in Treatment-Refractory Schizophrenic Patients

1998 • 91 citations

Risperidone vs. haloperidol on reaction time, manual dexterity, and motor learning in treatment-resistant schizophrenia patients

1998 • 89 citations

The Effect of Risperidone on Cognition in Patients with Schizophrenia

1996 • 86 citations

Different side effect profiles of risperidone and clozapine in 20 outpatients with schizophrenia or schizoaffective disorder: a pilot study

1996 • 74 citations

Reduction of Healthcare Resource Utilisation and Costs Following the Use of Risperidone for Patients with Schizophrenia Previously Treated with Standard Antipsychotic Therapy

1996 • 67 citations

Long-term impact of clozapine and psychosocial treatment on psychiatric symptoms and cognitive functioning

1996 • 62 citations

Neuropsychological performance in chronic schizophrenia in response to neuroleptic dose reduction

1993 • 60 citations

Cognitive impairment as a target for pharmacological treatment in schizophrenia

1995 • 60 citations

Sample size calculations in studies of test accuracy

1998 • 58 citations

Effects of clozapine, fluphenazine, and placebo on reaction time measures of attention and sensory dominance in schizophrenia

1994 • 58 citations

The cost of cognitive impairment in schizophrenia

1995 • 52 citations

The effects of clozapine on cognitive functioning in treatment- resistant schizophrenic patients

1997 • 48 citations

Full length article

1998 • 47 citations

The pharmacoeconomics of clozapine: a review.

1994 • 44 citations

Clozapine Treatment of Outpatients With Schizophrenia: Outcome and Long-Term Response Patterns

1993 • 43 citations

Recent Advances in the Pharmacotherapy of Schizophrenia

1997 • 36 citations

The Effects of Risperidone vs Haloperidol on Cognitive Functioning in Treatment-Resistant Schizophrenia: The Trail Making Test

1997 • 27 citations

Small sample longitudinal clinical trial with missing data: A comparison of analytic methods.

1999 • 25 citations

New antipsychotic medications

1997 • 17 citations

Novel Neuroleptics Improve Attentional Functioning in Schizophrenic Patients: Ziprasidone and Aripiprazole

1997 • 14 citations

Treatment of acute schizophrenia with ultra-high-dose fluphenazine: A failure at shortening time on a crisis-intervention unit

1975 • 11 citations

Small sample longitudinal clinical trial with missing data: A comparison of analytic methods.

1999 • 3 citations